Hunter C. Smith
2019
In 2019, Hunter C. Smith earned a total compensation of $1.9M as Chief Financial Officer, Treasurer, Secretary and Interim President and Chief Executive Officer at RHYTHM PHARMACEUTICALS, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $153,224 |
|---|---|
| Option Awards | $1,286,061 |
| Salary | $396,992 |
| Other | $86,576 |
| Total | $1,922,853 |
Smith received $1.3M in option awards, accounting for 67% of the total pay in 2019.
Smith also received $153.2K in non-equity incentive plan, $397K in salary and $86.6K in other compensation.
Rankings
In 2019, Hunter C. Smith's compensation ranked 6,147th out of 13,971 executives tracked by ExecPay. In other words, Smith earned more than 56.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,147 out of 13,971 | 56th |
Division Manufacturing | 2,304 out of 5,701 | 60th |
Major group Chemicals And Allied Products | 836 out of 2,200 | 62nd |
Industry group Drugs | 705 out of 1,886 | 63rd |
Industry Pharmaceutical Preparations | 520 out of 1,398 | 63rd |
Source: SEC filing on April 29, 2020.
Smith's colleagues
We found two more compensation records of executives who worked with Hunter C. Smith at RHYTHM PHARMACEUTICALS in 2019.